Home/Filings/4/0001209191-23-027204
4//SEC Filing

KIM AUSTIN D. 4

Accession 0001209191-23-027204

CIK 0001070494other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 9:14 PM ET

Size

7.9 KB

Accession

0001209191-23-027204

Insider Transaction Report

Form 4
Period: 2023-05-01
KIM AUSTIN D.
EVP AND GENERAL COUNSEL
Transactions
  • Award

    Restricted Stock Units

    2023-05-01+18,17218,172 total
    Common Stock (18,172 underlying)
  • Award

    Stock Options (Right to Buy)

    2023-05-01+59,95759,957 total
    Exercise: $21.75Exp: 2033-05-01Common Stock (59,957 underlying)
Footnotes (3)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on May 1, 2024. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
  • [F3]The restricted stock units vest in four equal annual installments beginning May 1, 2024.

Issuer

ACADIA PHARMACEUTICALS INC

CIK 0001070494

Entity typeother

Related Parties

1
  • filerCIK 0001746240

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 9:14 PM ET
Size
7.9 KB